期刊文献+

序贯联合应用HIV-1 gp160腺病毒载体疫苗的体液免疫效果研究 被引量:1

Study on humoral immune responses induced by immunization with Ad5-HIVgp160 alone or combined with other HIV vaccine
原文传递
导出
摘要 目的探讨序贯联合应用Ad5-HIVgp160疫苗与其他艾滋病疫苗所诱导的特异性体液免疫反应效果。方法用Ad5-HIVgp160疫苗、其他腺病毒载体和腺病毒相关载体疫苗以不同免疫程序分别免疫豚鼠,通过ELISA和中和实验方法检测其诱导的免疫反应,比较疫苗联合免疫组豚鼠与疫苗单独免疫组豚鼠诱导的体液免疫反应的强度。结果不同免疫程序的豚鼠均能检测到针对HIV gp120的HIV结合抗体和针对HIV敏感株sf162的中和活性;联合疫苗组诱导的gp120特异性抗体滴度和病毒中和活性高于单独免疫组,但无显著性差异。结论 Ad5-HIVgp160疫苗单独或与其他疫苗联合使用均能诱导高水平的体液免疫反应,能激发针对HIV敏感株产生中和活性的抗体。 Objective To study humoral immune response of Ad5-HIVgpl60 combined immunization strategy. Methods Guinea pigs were injected with Ad5-HIVgpl60 alone or combined with other HIV vaccine. Humoral immune response was detected by ELISA or neutralization assay. Results Compared with immunization of Ad5-HIVgpl60 alone, anti-gpl20 antibody titer and neutralizing antibody activity were slightly increased in combination group. Conclusion Ad5-HIVgpl60 induces robust humoral immune response alone or combined with other HIV vaccine.
出处 《公共卫生与预防医学》 2014年第3期5-7,共3页 Journal of Public Health and Preventive Medicine
基金 国家"十二五"科技重大专项资助(2012 ZX10001005 2012 ZX10001009-002-002 2013 ZX10001005-001-004)
关键词 艾滋病疫苗 gp160 GAG 腺病毒 腺相关病毒 AIDS vaccines gpl60 gag Adenovirus Adeno-associated virus
  • 相关文献

参考文献14

  • 1Excler JL, Robb ML, Kim JH. HIV-1 vaccines: Challenges and new perspectives [ J ]. Hum Vaccin Immunother,2014,10 (6).
  • 2Enama ME, Ledgerwood JE, Novik L. Phase I Randomized Clini- cal Trial of VRC DNA and rAd5 H1V-1 Vaccine Delivery by In- tramuscular ( IM ) , Subcutaneous ( SC ) and lntradermal ( ID ) Administration ( VRC 011) [ J ]. PLoS One,2014,9(3) :e91366.
  • 3Hammer SM, Sobieszczyk ME, Janes H, et al. Efficacy trial of a DNAZrAd5 HIV-1 preventive vaccine[J]. N Engl J Med,2013, 369 ( 22 ) : 2083 -92.
  • 4Muthumani K,Wise MC, Broderick KE HIV-1 Env DNA vaccine plus protein boost delivered by EP expands B-and T-cell respon- ses and neutralizing phenotype in vivo [ J ]. PLoS One, 2013,8 (12) : e84234.
  • 5Rerks-Ngarm S, Pitisuttithum P, Nitayaphan S. Vaccination with ALVAC and AIDSVAX to Prevent HIV-1 Infection in Thailand [J]. N Engl J ned,2007,361 (23) :2209-2220.
  • 6Haynes BF, Gilbert PB, McElrath M J, et al. Immune-correlates analysis of an HIV-1 vaccine efficacy trlal[J]. N Engl J Med, 2012,366(14) : 1275-86.
  • 7Morgane R,Paul TE, Brendan BL,et al. Increased HIV-1 vaccine efficacy against viruses with geneticsignatures in Env V2[ J ]. Na- ture ,2012 ;490:417-420.
  • 8杨海儒,张凌斐,冯霞,余双庆,庄著伦,李红霞,曾毅.表达HIV-1 B亚型env基因的质粒DNA及腺病毒载体疫苗的免疫原性研究[J].中华实验和临床病毒学杂志,2010,24(6):415-417. 被引量:4
  • 9叶晟,吴波,徐仕武.20例艾滋病人二线抗病毒药物治疗效果[J].公共卫生与预防医学,2013,24(6):109-110. 被引量:5
  • 10张芬,杨芳.新形势下湖北省艾滋病综合防治管理策略[J].公共卫生与预防医学,2011,22(6):87-88. 被引量:8

二级参考文献14

共引文献14

同被引文献14

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部